Q2 2024 EPS Estimates for Privia Health Group, Inc. Lifted by Leerink Partnrs (NASDAQ:PRVA)

Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) - Investment analysts at Leerink Partnrs lifted their Q2 2024 earnings per share estimates for shares of Privia Health Group in a research report issued on Thursday, May 9th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $0.08 per share for the quarter, up from their previous estimate of $0.07. The consensus estimate for Privia Health Group's current full-year earnings is $0.26 per share. Leerink Partnrs also issued estimates for Privia Health Group's Q2 2025 earnings at $0.10 EPS, Q3 2025 earnings at $0.12 EPS and Q4 2025 earnings at $0.10 EPS.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). The company had revenue of $440.80 million during the quarter, compared to analysts' expectations of $425.81 million. Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. The business's quarterly revenue was up 21.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.14 EPS.

A number of other analysts also recently issued reports on the company. Evercore ISI decreased their price target on Privia Health Group from $26.00 to $25.00 and set an "outperform" rating for the company in a report on Wednesday, February 28th. JPMorgan Chase & Co. decreased their price target on Privia Health Group from $38.00 to $30.00 and set an "overweight" rating for the company in a report on Wednesday, March 6th. Citigroup assumed coverage on Privia Health Group in a report on Monday, April 22nd. They set a "buy" rating and a $25.00 price target for the company. UBS Group decreased their price target on Privia Health Group from $31.00 to $29.00 and set a "buy" rating for the company in a report on Friday, March 1st. Finally, Barclays started coverage on Privia Health Group in a report on Wednesday, March 6th. They set an "equal weight" rating and a $22.00 price target for the company. Two research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat.com, Privia Health Group currently has an average rating of "Moderate Buy" and a consensus price target of $25.67.

Privia Health Group Stock Performance

Shares of PRVA traded up $0.02 during midday trading on Monday, hitting $17.99. The company had a trading volume of 825,799 shares, compared to its average volume of 951,398. The company's 50-day simple moving average is $19.24 and its 200-day simple moving average is $20.92. The firm has a market capitalization of $2.15 billion, a P/E ratio of 119.93, a P/E/G ratio of 2.24 and a beta of 0.81. Privia Health Group has a 1 year low of $16.90 and a 1 year high of $29.42.

Hedge Funds Weigh In On Privia Health Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in PRVA. New York State Teachers Retirement System increased its position in Privia Health Group by 33.8% during the 3rd quarter. New York State Teachers Retirement System now owns 58,204 shares of the company's stock worth $1,339,000 after purchasing an additional 14,700 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Privia Health Group by 13.8% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 20,829 shares of the company's stock worth $479,000 after acquiring an additional 2,518 shares during the period. Strs Ohio grew its holdings in shares of Privia Health Group by 42.9% in the 3rd quarter. Strs Ohio now owns 20,000 shares of the company's stock worth $460,000 after acquiring an additional 6,000 shares during the period. Oregon Public Employees Retirement Fund grew its holdings in shares of Privia Health Group by 3.8% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 30,300 shares of the company's stock worth $697,000 after acquiring an additional 1,100 shares during the period. Finally, TD Asset Management Inc grew its holdings in shares of Privia Health Group by 23.0% in the 3rd quarter. TD Asset Management Inc now owns 242,060 shares of the company's stock worth $5,567,000 after acquiring an additional 45,246 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

Insider Buying and Selling at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 13,869 shares of the company's stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $17.88, for a total transaction of $247,977.72. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares of the company's stock, valued at approximately $4,430,145.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Privia Health Group news, CFO David Mountcastle sold 3,933 shares of the business's stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total transaction of $69,889.41. Following the transaction, the chief financial officer now owns 262,279 shares in the company, valued at approximately $4,660,697.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Parth Mehrotra sold 13,869 shares of the business's stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $17.88, for a total value of $247,977.72. Following the transaction, the chief executive officer now owns 247,771 shares in the company, valued at approximately $4,430,145.48. The disclosure for this sale can be found here. Insiders sold a total of 49,390 shares of company stock valued at $897,700 in the last ninety days. Insiders own 14.20% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.